| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
An Approach to the Rational Use of Revascularization in Heart Failure Patients
|
Rouleau, Jean L.
|
|
2014
|
30 |
3 |
p. 281-287
7 p.
|
article
|
| 2 |
A Novel Approach to Drug Development in Heart Failure: Towards Personalized Medicine
|
Liu, Licette C.Y.
|
|
2014
|
30 |
3 |
p. 288-295
8 p.
|
article
|
| 3 |
Assessing the Burden of Hospitalized and Community-Care Heart Failure in Canada
|
Blais, Claudia
|
|
2014
|
30 |
3 |
p. 352-358
7 p.
|
article
|
| 4 |
Conceptual Model for Heart Failure Disease Management
|
Andrikopoulou, Efstathia
|
|
2014
|
30 |
3 |
p. 304-311
8 p.
|
article
|
| 5 |
Congenital Absence of Nitric Oxide Synthase 3 Potentiates Cardiac Dysfunction and Reduces Survival in Doxorubicin- and Trastuzumab-Mediated Cardiomyopathy
|
Zeglinski, Matthew
|
|
2014
|
30 |
3 |
p. 359-367
9 p.
|
article
|
| 6 |
Destination Therapy With Left Ventricular Assist Devices: For Whom and When?
|
Porepa, Liane F.
|
|
2014
|
30 |
3 |
p. 296-303
8 p.
|
article
|
| 7 |
Editorial Board
|
|
|
2014
|
30 |
3 |
p. A3-
1 p.
|
article
|
| 8 |
Effects of the Metabolic Syndrome on Right Heart Mechanics and Function
|
Tadic, Marijana
|
|
2014
|
30 |
3 |
p. 325-331
7 p.
|
article
|
| 9 |
Growth Differentiation Factor-15 Is a Useful Prognostic Marker in Patients With Heart Failure With Preserved Ejection Fraction
|
Izumiya, Yasuhiro
|
|
2014
|
30 |
3 |
p. 338-344
7 p.
|
article
|
| 10 |
Heart Failure Clinics Are Still Useful (More Than Ever?)
|
Jaarsma, Tiny
|
|
2014
|
30 |
3 |
p. 272-275
4 p.
|
article
|
| 11 |
Hypouricemic Effects of Prednisone and Allopurinol: An Uneven Playing Field?
|
Kannangara, Diluk R.W.
|
|
2014
|
30 |
3 |
p. 376.e1-
1 p.
|
article
|
| 12 |
Impaired Cardiac Function in Metabolic Syndrome
|
Fitchett, David
|
|
2014
|
30 |
3 |
p. 270-271
2 p.
|
article
|
| 13 |
Information for Readers
|
|
|
2014
|
30 |
3 |
p. A10-
1 p.
|
article
|
| 14 |
Left Ventricular Myocardial Dyssynchrony Is Already Present in Nondiabetic Patients With Metabolic Syndrome
|
Crendal, Edward
|
|
2014
|
30 |
3 |
p. 320-324
5 p.
|
article
|
| 15 |
QRS Widening Rates and Genetic Polymorphisms of Matrix Metalloproteinases in a Cohort of Patients With Chronic Heart Failure
|
Olsen, Virgilio
|
|
2014
|
30 |
3 |
p. 345-351
7 p.
|
article
|
| 16 |
Reduced Endoplasmic Reticulum Stress Might Alter the Course of Heart Failure Via Caspase-12 and JNK Pathways
|
Liu, Yu
|
|
2014
|
30 |
3 |
p. 368-375
8 p.
|
article
|
| 17 |
Reply to Day et al.—Hypouricemic Effect of Prednisone in Heart Failure: Possible Mechanisms
|
Liu, Chao
|
|
2014
|
30 |
3 |
p. 376.e3-
1 p.
|
article
|
| 18 |
Risk Stratification in Acute Heart Failure
|
Lee, Douglas S.
|
|
2014
|
30 |
3 |
p. 312-319
8 p.
|
article
|
| 19 |
Role of Autoimmunity in Heart Disease: Is Chagas Heart Disease the Definitive Proof?
|
McLean, Brent A.
|
|
2014
|
30 |
3 |
p. 267-269
3 p.
|
article
|
| 20 |
β1-Selective Adrenoceptor Antagonists Increase Plasma Levels of Anti-p2β Antibodies and Decrease Cardiac Involvement in Chronic Progressive Chagas Heart Disease
|
Vicco, Miguel H.
|
|
2014
|
30 |
3 |
p. 332-337
6 p.
|
article
|
| 21 |
Specialist Heart Failure Clinics Must Evolve to Stay Relevant
|
Howlett, Jonathan G.
|
|
2014
|
30 |
3 |
p. 276-280
5 p.
|
article
|
| 22 |
Table of Contents
|
|
|
2014
|
30 |
3 |
p. A5-
1 p.
|
article
|
| 23 |
The 2013 Canadian Cardiovascular Society Heart Failure Management Guidelines Update: Focus on Rehabilitation and Exercise and Surgical Coronary Revascularization
|
Moe, Gordon W.
|
|
2014
|
30 |
3 |
p. 249-263
15 p.
|
article
|
| 24 |
The Harbinger of Mortality in Heart Failure With Preserved Ejection Fraction: Do GDF-15 Levels Reflect Tandem, Deterministic Effects of Fibrosis and Inflammation?
|
Putko, Brendan N.
|
|
2014
|
30 |
3 |
p. 264-266
3 p.
|
article
|
Journal description